Ibrahim B. Dagher Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

BCLI Quotes by TradingView

Ibrahim B. Dagher is Chief Medical Officer of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 66,849 shares of BCLI, which is worth approximately $44,788. The most recent transaction as insider was on Jan 01, 2025, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.8K
0% 3M change
Infinity% 12M change
Total Value Held $44,788

Ibrahim B. Dagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2025
BUY
Grant, award, or other acquisition
-
50,000 Added 42.79%
66,849 Common Stock
Jul 19 2024
SELL
Open market or private sale
$22,050 $0.35 p/Share
63,000 Reduced 100.0%
0 Common Stock
IBD

Ibrahim B. Dagher

Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCLI